Characterization of endoglin and Ki-67 expression in endothelial cells from benign and malignant lesions of the uterine cervix: Rapid Communication

Pathology International

Volumn 59, Issue 10, 2009, Pages 695-700

  Cimpean, Anca M ^a   Saptefrati, Lilian ^b   Ceausu, Raluca ^a   Raica, Marius ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b STATE UNIVERSITY OF MEDICINE AND PHARMACY NICOLAE TESTEMITANU   (Moldova)

Author keywords

CD105; Endoglin; Immunohistochemistry; Ki 67; Uterine cervix

Indexed keywords

ENDOGLIN; KI 67 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SQUAMOUS CELL METAPLASIA; TUMOR CELL; TUMOR VASCULARIZATION; UTERINE CERVIX CARCINOMA IN SITU;

ANTIGENS, CD; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; METAPLASIA; NEOVASCULARIZATION, PATHOLOGIC; PRECANCEROUS CONDITIONS; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 70349482667     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2009.02431.x     Document Type: Article

References (31)

1. Burrows FJ, Derbyshire EJ, Tazzari PL et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy. Clin Cancer Res 1995 1 : 1623 1634.
2. Miller DW, Graulich W, Karges B et al. Elevated expression of endoglin, a component of the TGF-β-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 1999 81 : 568 572.
3. Fonsatti E, Jekunen AP, Kairemo KJ et al. Endoglin is a suitable target for efficient imaging of solid tumors: In vivo evidence in a canine mammary carcinoma model. Clin Cancer Res 2000 6 : 2037 2043.
4. Fonsatti E, Del Vecchio L, Altomonte M et al. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001 188 : 1 7.
5. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M. Endoglin (CD105): A powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003 22 : 6557 6563.
6. Yu JX, Zhang XT, Liao YQ et al. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance. World J Gastroenterol 2003 9 : 2866 2869.
7. Cheifetz S, Bellón T, Calés C et al. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 1992 267 : 19 027 30.
8. Lastres P, Letamendía A, Zhang H et al. Endoglin modulates cellular response to TGF-β1. J Cell Biol 1996 133 : 1109 1121.
9. Pepper MS. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997 8 : 21 43.
10. Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000 182 : 311 322.
11. Lebrin F, Goumans MJ, Jonker L et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 2004 23 : 4018 4028.
12. Venkatesha S, Toporsian M, Lam C. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006 12 : 642 649. (Pubitemid 43865232)
13. Benetti A, Berenzi A, Gambarotti M et al. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Cancer Res 2008 68 : 8626 8634.
14. Li C, Issa R, Kumar P et al. CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003 116 : 2677 2685.
15. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995 36 : 169 180.
16. Magne N, Chargari C, Deutsch E et al. Molecular profiling of uterine cervix carcinoma: An overview with a special focus on rationally designed target-based anticancer agents. Cancer Met Rev 2008 24 : 737 750.
17. Vieira SC, Zeferino LC, da Silva BB et al. Quantification of angiogenesis in cervical cancer: A comparison among three endothelial cell markers. Gynecol Oncol 2004 93 : 121 124.
18. Vieira SC, Silva BB, Pinto GA et al. CD34 as a marker for evaluating angiogenesis in cervical cancer. Pathol Res Pract 2005 201 : 313 318.
19. Lenczewski A, Terlikowski S, Famulski W, Sulkowska M, Kulikowski M. Angiogenesis as a prognostic factor in invasive carcinoma of the uterine cervix. Folia Histochem Cytobiol 2001 39 : 165 166.
20. Mazibrada J, Rittà M, Mondini M et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol 2008 108 : 112 120.
21. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J Biol Chem 1999 274 : 584 594.
22. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 2006 56 : 717 723.
23. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001 29 : 117 129. (Pubitemid 32952643)
24. Roberts AB, Wakefield LM. The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci USA 2003 100 : 8621 8623.
25. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 2004 17 : 197 203.
26. Wikström P, Lissbrant IF, Stattin P, Egevad L, Bergh A. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 2002 51 : 268 275.
27. Dallas NA, Samuel S, Xia L et al. Endoglin (CD105): A marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008 14 : 1931 1937.
28. Grisanti S, Canbek S, Kaiserling E et al. Expression of endoglin in choroidal neovascularization. Exp Eye Res 2004 78 : 207 213.
29. Gu X, Xu Y, Wu H, Xu X. Relationship between CD105 and angiogenesis and biological behaviours in squamous carcinoma of larynx. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006 20 : 125 128.
30. Màrgàritescu C, Simionescu C, Pirici D, Mogoantà L, Ciurea R, Stepan A. Immunohistochemical characterization of tumoral vessels in oral squamous cell carcinoma. Rom J Morphol Embryol 2008 49 : 447 458.
31. Ziemssen F, Wegner R, Wegner J et al. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: Is there prognostic relevance of proliferating endothelium? Graefes Arch Clin Exp Ophthalmol 2006 244 : 1124 1131.